4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Respecting Choices and Related Models of Advance Care Planning: A Systematic Review of Published Evidence

      1 , 2 , 3 , 2
      American Journal of Hospice and Palliative Medicine®
      SAGE Publications

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="P1">All individuals should receive care consistent with their expressed preferences during serious and chronic illnesses. Respecting Choices® is a well-known model of advance care planning (ACP) intended to assist individuals consider, choose and communicate these preferences to health care providers. In this systematic review, we evaluated the published literature on the outcomes of the Respecting Choices® and derivative models utilizing criteria developed by the Cochrane Collaborative. </p><p id="P2">Eighteen articles from 16 studies were included, of which nine were randomized control trials, six were observational and one was a pre-posttest study. Only two specifically included a minority population (African American). Fourteen were conducted in the United States, primarily in the Wisconsin/Minnesota region (n=8). Seven studies examined the Respecting Choices® model, while nine examined derivative models. There was significant heterogeneity of outcomes examined. </p><p id="P3">We found that there is a low level of evidence that Respecting Choices® and derivative models increase the incidence and prevalence of Advance Directive and Physician Orders for Life-Sustaining Treatment (POLST) completion. There is a high level of evidence that Respecting Choices® and derivative models increase patient-surrogate congruence in Caucasian populations. The evidence is mixed, inconclusive and too poor in quality to determine whether Respecting Choices® and derivative models change the consistency of treatment with wishes and overall healthcare utilization in the end of life. We urge further studies be conducted, particularly with minority populations and focused on the outcomes of preference-congruent treatment and health care utilization. </p>

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          Defining Advance Care Planning for Adults: A Consensus Definition From a Multidisciplinary Delphi Panel.

          Despite increasing interest in advance care planning (ACP) and previous ACP descriptions, a consensus definition does not yet exist to guide clinical, research, and policy initiatives.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            End-of-life care discussions among patients with advanced cancer: a cohort study.

            National guidelines recommend that physicians discuss end-of-life (EOL) care planning with patients with cancer whose life expectancy is less than 1 year. To evaluate the incidence of EOL care discussions for patients with stage IV lung or colorectal cancer and where, when, and with whom these discussions take place. Prospective cohort study of patients diagnosed with lung or colorectal cancer from 2003 to 2005. Participants lived in Northern California, Los Angeles County, North Carolina, Iowa, or Alabama or received care in 1 of 5 large HMOs or 1 of 15 Veterans Health Administration sites. 2155 patients with stage IV lung or colorectal cancer. End-of-life care discussions reported in patient and surrogate interviews or documented in medical records through 15 months after diagnosis. 73% of patients had EOL care discussions identified by at least 1 source. Among the 1470 patients who died during follow-up, 87% had EOL care discussions, compared with 41% of the 685 patients who were alive at the end of follow-up. Of the 1081 first EOL care discussions documented in records, 55% occurred in the hospital. Oncologists documented EOL care discussions with only 27% of their patients. Among 959 patients with documented EOL care discussions who died during follow-up, discussions took place a median of 33 days before death. The depth and quality of EOL care discussions was not evaluated. Much of the information about discussions came from surrogates of patients who died before baseline interviews could be obtained. Although most patients with stage IV lung or colorectal cancer discuss EOL care planning with physicians before death, many discussions occur during acute hospital care, with providers other than oncologists, and late in the course of illness. National Cancer Institute and Department of Veterans Affairs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies.

              The GRADE approach to grading the quality of evidence and strength of recommendations provides a comprehensive and transparent approach for developing clinical recommendations about using diagnostic tests or diagnostic strategies. Although grading the quality of evidence and strength of recommendations about using tests shares the logic of grading recommendations for treatment, it presents unique challenges. Guideline panels and clinicians should be alert to these special challenges when using the evidence about the accuracy of tests as the basis for clinical decisions. In the GRADE system, valid diagnostic accuracy studies can provide high quality evidence of test accuracy. However, such studies often provide only low quality evidence for the development of recommendations about diagnostic testing, as test accuracy is a surrogate for patient-important outcomes at best. Inferring from data on accuracy that using a test improves outcomes that are important to patients requires availability of an effective treatment, improved patients' wellbeing through prognostic information, or - by excluding an ominous diagnosis - reduction of anxiety and the opportunity for earlier search for an alternative diagnosis for which beneficial treatment can be available. Assessing the directness of evidence supporting the use of a diagnostic test requires judgments about the relationship between test results and patient-important consequences. Well-designed and conducted studies of allergy tests in parallel with efforts to evaluate allergy treatments critically will encourage improved guideline development for allergic diseases.
                Bookmark

                Author and article information

                Journal
                American Journal of Hospice and Palliative Medicine®
                Am J Hosp Palliat Care
                SAGE Publications
                1049-9091
                1938-2715
                November 27 2017
                June 2018
                December 18 2017
                June 2018
                : 35
                : 6
                : 897-907
                Affiliations
                [1 ]College of Nursing, Villanova University, Villanova, PA, USA
                [2 ]School of Nursing, University of Pennsylvania, Philadelphia, PA, USA
                [3 ]Geriatrics, Excellus BlueCross BlueShield and MedAmerica Insurance Company, Rochester, NY, USA
                Article
                10.1177/1049909117745789
                6580846
                29254357
                8104d3f9-0e15-41fe-8b34-57a949428483
                © 2018

                http://journals.sagepub.com/page/policies/text-and-data-mining-license

                History

                Comments

                Comment on this article